• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Ashland Inc. (Amendment)

    1/30/23 1:22:57 PM ET
    $ASH
    Specialty Chemicals
    Consumer Discretionary
    Get the next $ASH alert in real time by email
    SC 13G/A 1 ashl22a1.htm ashl22a1.htm - Generated by SEC Publisher for SEC Filing  

     

            CUSIP NO.  044186104                        13G                            Page 1 of 7

     

                                                                                       UNITED STATES

                                                                  SECURITIES AND EXCHANGE COMMISSION

                                                                              Washington, D.C. 20549

     

                                                                                        SCHEDULE 13G

     

                                                           Under the Securities Exchange Act of 1934

                                                                                  (Amendment No. 1)*

     

                                                                                        ASHLAND INC.

                                                                                    (Name of Issuer)

     

                                                              Common Stock, par value $.01 per share

     

                                                                      (Title of Class of Securities)

     

                                                                                           044186104

                                                                                      (CUSIP Number)

     

                                                                                   December 31, 2022

                                             (Date of Event Which Requires Filing of this Statement)

     

              Check the appropriate box to designate the rule pursuant to which this Schedule is

              filed:

     

              [X] Rule 13d‑1(b)

              [ ] Rule 13d‑1(c)

              [ ] Rule 13d‑1(d)

     

              *The remainder of this cover page shall be filled out for a reporting person's initial

              filing on this form with respect to the subject class of securities, and for any

              subsequent amendment containing information which would alter the disclosures provided

              in a prior cover page.

     

              The information required in the remainder of this cover page shall not be deemed to be

              "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or

              otherwise subject to the liabilities of that section of the Act but shall be subject to

              all other provisions of the Act (however, see the Notes).

     

     


     
     

     

            CUSIP NO.  044186104                        13G                            Page 2 of 7

     

              1.   NAMES OF REPORTING PERSONS.    

     

                         Franklin Mutual Advisers, LLC

     

              2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

                         (a)

                         (b) X

     

              3.   SEC USE ONLY

     

              4.   CITIZENSHIP OR PLACE OF ORGANIZATION

     

                         Delaware

     

              NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

     

                         5.   SOLE VOTING POWER

     

                                    (See Item 4)

     

                         6.   SHARED VOTING POWER

     

                                    (See Item 4)

     

                         7.   SOLE DISPOSITIVE POWER

     

                                    (See Item 4)

     

                         8.   SHARED DISPOSITIVE POWER

     

                                    (See Item 4)

     

              9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

                        1,683,651

     

              10.  CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

                         CERTAIN SHARES [ ]

     

              11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

                         3.1%

     

              12.  TYPE OF REPORTING PERSON

     

                         IA, OO (See Item 4)

     

     


     
     

     

            CUSIP NO.  044186104                        13G                            Page 3 of 7

     

              Item 1.

     

              (a)   Name of Issuer

     

                          ASHLAND INC.

     

              (b)   Address of Issuer's Principal Executive Offices

     

               8145 Blazer Drive

               Wilmington, DE 19808

     

              Item 2.

     

              (a)   Name of Person Filing

     

                          Franklin Mutual Advisers, LLC

     

              (b)   Address of Principal Business Office or, if none, Residence

     

                          101 John F. Kennedy Parkway

                          Short Hills, NJ 07078‑2789

     

              (c)   Citizenship

     

                          Delaware

     

              (d)   Title of Class of Securities

     

                          Common Stock, par value $.01 per share

     

              (e)   CUSIP Number

     

                          044186104

     

     


     
     

     

            CUSIP NO.  044186104                        13G                            Page 4 of 7

     

              Item 3. If this statement is filed pursuant to §§240.13d‑1(b) or 240.13d‑2(b) or (c),

                              check whether the person filing is a:

                              (a) [ ]  Broker or dealer registered under section 15 of the Act (15 U.S.C. 8o).

     

                              (b) [ ]  Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     

                              (c) [ ]  Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C.

                                                78c).

     

                              (d) [ ]  Investment company registered under section 8 of the Investment Company

                                                Act of 1940 (15 U.S.C 80a ‑8).

     

                              (e) [X]  An investment adviser in accordance with §240.13d‑1(b)(1)(ii)(E);

     

                              (f) [ ]  An employee benefit plan or endowment fund in accordance with

                                                §240.13d‑1(b)(1)(ii)(F);

     

                              (g) [ ]  A parent holding company or control person in accordance with

                                                §240.13d‑1(b)(1)(ii)(G);

     

                              (h) [ ]  A savings associations as defined in Section 3(b) of the Federal

                                                Deposit Insurance Act (12 U.S.C. 1813);

     

                              (i) [ ]  A church plan that is excluded from the definition of an investment

                                                company under section 3(c)(14) of the Investment Company Act of 1940

                                                (15 U.S.C. 80a‑3);

     

                              (j) [ ]  A non‑U.S. institution in accordance with §240.13d‑1(b)(ii)(J);

     

                              (k) [ ]  Group, in accordance with §240.13d‑1(b)(1)(ii)(K).

     

                              If filing as a non‑U.S. institution in accordance with §240.13d‑1(b)(1)(ii)(J),

                              please specify the type of institution

     

     


     
     

     

            CUSIP NO.  044186104                        13G                            Page 5 of 7

     

              Item 4. Ownership

     

              The securities reported herein are beneficially owned by one or more open‑end investment

              companies or other managed accounts that are investment management clients of Franklin

              Mutual Advisers, LLC ("FMA"), an indirect wholly owned subsidiary of Franklin Resources,

              Inc. ("FRI"). When an investment management contract (including a sub‑advisory

              agreement) delegates to FMA investment discretion or voting power over the securities

              held in the investment advisory accounts that are subject to that agreement, FRI treats

              FMA as having sole investment discretion or voting authority, as the case may be, unless

              the agreement specifies otherwise. Accordingly, FMA reports on Schedule 13G that it has

              sole investment discretion and voting authority over the securities covered by any such

              investment management agreement, unless otherwise noted in this Item 4. As a result for

              purposes of Rule 13d‑3 under the Act, FMA may be deemed to be the beneficial owner of

              the securities reported in this Schedule 13G.

     

              Beneficial ownership by investment management subsidiaries and other affiliates of FRI

              is being reported in conformity with the guidelines articulated by the SEC staff in

              Release No. 34‑39538 (January 12, 1998) relating to organizations, such as FRI, where

              related entities exercise voting and investment powers over the securities being

              reported independently from each other. The voting and investment powers held by FMA are

              exercised independently from FRI (FMA’s parent holding company) and from all other

              investment management subsidiaries of FRI (FRI, its affiliates and investment management

              subsidiaries other than FMA are, collectively, “FRI affiliates”). Furthermore, internal

              policies and procedures of FMA and FRI affiliates establish informational barriers that

              prevent the flow between FMA and the FRI affiliates of information that relates to the

              voting and investment powers over the securities owned by their respective investment

              management clients. Consequently, FMA and the FRI affiliates report the securities over

              which they hold investment and voting power separately from each other for purposes of

         Section 13 of the Act.

     

              Charles B. Johnson and Rupert H. Johnson, Jr. (the "Principal Shareholders") each own in

              excess of 10% of the outstanding common stock of FRI and are the principal stockholders

              of FRI. However, because FMA exercises voting and investment powers on behalf of its

              investment management clients independently of FRI affiliates, beneficial ownership of

              the securities reported by FMA is not attributed to the Principal Shareholders. FMA

              disclaims any pecuniary interest in any of the securities reported in this Schedule 13G. 

              In addition, the filing of this Schedule 13G on behalf of FMA should not be construed as

              an admission that it is, and it disclaims that it is, the beneficial owner, as defined

              in Rule 13d‑3, of any of such securities.

     

              Furthermore, FMA believes that it is not a "group" with FRI affiliates, the Principal

              Shareholders, or their respective affiliates within the meaning of Rule 13d‑5 under the

              Act and that none of them is otherwise required to attribute to any other the beneficial

              ownership of the securities held by such person or by any persons or entities for whom

              or for which FMA or the FRI affiliates provide investment management

              services.

     

     


     
     

     

            CUSIP NO.  044186104                        13G                            Page 6 of 7

     

                  (a)    Amount beneficially owned:

     

                               1,683,651

                  (b)    Percent of class:

     

                                3.1%

     

                  (c)    Number of shares as to which the person has:

     

                          (i)   Sole power to vote or to direct the vote

     

                                        Franklin Mutual Advisers, LLC:                               1,668,916

     

                        (ii)   Shared power to vote or to direct the vote

     

                                        0

     

                      (iii)   Sole power to dispose or to direct the disposition of

     

                                        Franklin Mutual Advisers, LLC:                               1,683,651

     

                        (iv)   Shared power to dispose or to direct the disposition of

     

                                        0

     

              Item 5.  Ownership of Five Percent or Less of a Class

     

                                If this statement is being filed to report the fact that as of the date hereof

                                the reporting person has ceased to be the beneficial owner of more than five

                                percent of the class of securities, check the following [X].

     

              Item 6.  Ownership of More than Five Percent on Behalf of Another Person

     

                                The clients of Franklin Mutual Advisers, LLC, including investment companies

                                registered under the Investment Company Act of 1940 and other managed accounts,

                                have the right to receive or power to direct the receipt of dividends from, and

                                the proceeds from the sale of, the securities reported herein.

     

     

     

              Item 7. Identification and Classification of the Subsidiary Which Acquired the

                              Security Being Reported on By the Parent Holding Company

     

                              Not Applicable

     

              Item 8. Identification and Classification of Members of the Group

     

                              Not Applicable

     

              Item 9. Notice of Dissolution of Group

     

                              Not Applicable

     

     


     
     

     

            CUSIP NO.  044186104                        13G                            Page 7 of 7

     

              Item 10. Certification

     

              By signing below I certify that, to the best of my knowledge and belief, the securities

              referred to above were acquired and are held in the ordinary course of business and were

              not acquired and are not held for the purpose of or with the effect of changing or

              influencing the control of the issuer of the securities and were not acquired and are

              not held in connection with or as a participant in any transaction having that purpose

              or effect, other than activities solely in connection with a nomination under §

              240.14a‑11.

     

     

                                                                                      SIGNATURE

     

              After reasonable inquiry and to the best of my knowledge and belief, I certify that the

              information set forth in this statement is true, complete and correct.

     

              Dated:      January 24, 2023

     

              Franklin Mutual Advisers, LLC

     

              By:    /s/STEVEN J. GRAY

                            ‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑

                            Steven J. Gray

                            Assistant Secretary of Franklin Mutual Advisers, LLC

     

    Get the next $ASH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASH

    DatePrice TargetRatingAnalyst
    5/1/2025Overweight → Equal Weight
    Wells Fargo
    3/26/2025$68.00 → $71.00Neutral → Overweight
    Analyst
    3/5/2025Buy → Neutral
    Seaport Research Partners
    8/8/2024$90.00 → $89.00Underweight → Neutral
    JP Morgan
    4/11/2024$100.00 → $112.00Equal Weight → Overweight
    Wells Fargo
    3/14/2024$100.00 → $126.00Hold → Buy
    Jefferies
    3/1/2024$108.00Outperform
    Wolfe Research
    6/29/2023Outperform → In-line
    Evercore ISI
    More analyst ratings

    $ASH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Valvoline Inc. Announces Kevin Willis as Chief Financial Officer

      Valvoline Inc. announces that Kevin Willis will become the Company's next Chief Financial Officer (CFO), effective May 19, 2025Current CFO, Mary Meixelsperger, whose planned retirement was announced October 2024, will remain with the company through a transition periodLEXINGTON, Ky., May 8, 2025 /PRNewswire/ -- Valvoline Inc. (NYSE:VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced that Kevin Willis will succeed Mary Meixelsperger as Valvoline Inc.'s Chief Financial Officer effective May 19. Willis brings significant public company experience to Valvoline including capital markets management, financial systems integrations, and operating efficiency im

      5/8/25 6:45:00 AM ET
      $ASH
      $VVV
      Specialty Chemicals
      Consumer Discretionary
      Major Chemicals
      Industrials
    • Ashland board authorizes quarterly dividend

      WILMINGTON, Del., May 06, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock which represents a 2.5 percent increase from the previous quarter. The dividend will be payable on June 15, 2025, to stockholders of record at the close of business on June 1, 2025. As of April 30, 2025, there were 45,696,225 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of

      5/6/25 5:15:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland announces executive leadership changes

      WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan

      5/5/25 5:00:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chair of the Board and CEO Novo Guillermo bought $2,010,327 worth of shares (31,294 units at $64.24) (SEC Form 4)

      4 - ASHLAND INC. (0001674862) (Issuer)

      2/3/25 4:30:05 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SVP and GM, Life Sciences Assis Alessandra Faccin bought $201,600 worth of shares (3,150 units at $64.00) (SEC Form 4)

      4 - ASHLAND INC. (0001674862) (Issuer)

      2/3/25 4:30:03 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Leadership Updates

    Live Leadership Updates

    See more
    • Ashland announces executive leadership changes

      WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan

      5/5/25 5:00:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland

      Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), the former nutraceuticals business of Ashland Inc. (NYSE:ASH). Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem. Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufactu

      9/3/24 7:00:00 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions

      Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent company, following the acquisition of the Company from Ashland, Inc. (NYSE:ASH) by Turnspire Capital Partners LLC ("Turnspire"). Headquartered in Kearny, NJ, Pharmachem has a long history of working closely with customers around the world to develop and produce a wide range of specialized nutraceuticals. From its manufacturing facilities in New Jersey and Utah in the United States and Tamaulipas, Mexico, Pharmachem produces a wide range of proprietary and private labeled products used in many applications, including hydratio

      9/3/24 7:00:00 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Financials

    Live finance-specific insights

    See more
    • Ashland board authorizes quarterly dividend

      WILMINGTON, Del., May 06, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock which represents a 2.5 percent increase from the previous quarter. The dividend will be payable on June 15, 2025, to stockholders of record at the close of business on June 1, 2025. As of April 30, 2025, there were 45,696,225 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of

      5/6/25 5:15:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland reports second quarter fiscal 2025 results and revises full-year outlook

      Sales of $479 million, down 17 percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), nutraceuticals and Avoca portfolio optimization initiatives (collectively, "Portfolio Optimization") reduced overall sales by approximately $67 million or 12 percent versus the prior-year quarter. Excluding these initiatives, sales declined five percent.Income from continuing operations of $30 million, or $0.63 per diluted shareAdjusted income from continuing operations excluding intangibles amortization expense of $46 million, or $0.99 per diluted shareNet income of $31 million, or $0.65 per diluted shareAdjusted EBITDA of $108 million, down 14 percent f

      4/30/25 5:01:00 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast

      WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, April 30, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Thursday, May 1. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerKevin Willis, senior vice president and chief financia

      4/17/25 6:30:00 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kulkarni Ashish K converted options into 1,032 shares (SEC Form 4)

      4 - ASHLAND INC. (0001674862) (Issuer)

      5/8/25 4:30:05 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 4 filed by Director Chattopadhyay Sanat

      4 - ASHLAND INC. (0001674862) (Issuer)

      4/1/25 5:00:05 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 4 filed by Director Bishop Steven D

      4 - ASHLAND INC. (0001674862) (Issuer)

      4/1/25 5:00:04 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    SEC Filings

    See more
    • Ashland Inc. filed SEC Form 8-K: Leadership Update

      8-K - ASHLAND INC. (0001674862) (Filer)

      5/5/25 5:00:09 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form 10-Q filed by Ashland Inc.

      10-Q - ASHLAND INC. (0001674862) (Filer)

      5/1/25 4:04:10 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ASHLAND INC. (0001674862) (Filer)

      4/30/25 5:14:56 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ashland Inc.

      SC 13G - ASHLAND INC. (0001674862) (Subject)

      11/12/24 11:54:03 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Ashland Inc.

      SC 13G/A - ASHLAND INC. (0001674862) (Subject)

      7/10/24 1:14:41 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Ashland Inc. (Amendment)

      SC 13D/A - ASHLAND INC. (0001674862) (Subject)

      4/25/24 4:15:12 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary

    $ASH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Ashland downgraded by Wells Fargo

      Wells Fargo downgraded Ashland from Overweight to Equal Weight

      5/1/25 3:02:01 PM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland upgraded by Analyst with a new price target

      Analyst upgraded Ashland from Neutral to Overweight and set a new price target of $71.00 from $68.00 previously

      3/26/25 7:45:24 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary
    • Ashland downgraded by Seaport Research Partners

      Seaport Research Partners downgraded Ashland from Buy to Neutral

      3/5/25 7:22:09 AM ET
      $ASH
      Specialty Chemicals
      Consumer Discretionary